戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s were 199 superficial femoral arteries, 110 popliteal, 218 tibials, and 52 multilevel.
2 Accumulation of the nonspecific agent by the popliteal and axillary nodes at 6-hr postinjection was a
3                                              Popliteal and axillary nodes were then assayed for perce
4 p < 0.01) were directly associated with both popliteal and carotid intimal-medial thicknesses.
5 e present analyses are based on the baseline popliteal and carotid ultrasonography examination in 10,
6 ial (TRP) channel TRPC3 were present in both popliteal and first order intramuscular arterioles.
7 ode (LN) excision, consisting of ipsilateral popliteal and inguinal LN excision and to evaluate the i
8 ons in lymph drainage through tumor-draining popliteal and inguinal LNs versus contralateral uninvolv
9                                          The popliteal and inguinal lymph nodes were excised ipsilate
10 also related to early thickening of both the popliteal and the carotid artery walls.
11 imes to the common femoral artery (CFA), the popliteal and tibial arteries, and the corresponding vei
12 angioplasty, and atherectomy of the femoral, popliteal, and tibial vessels.
13 cond and first order arterioles vs. feed and popliteal arteries (58% and 16% vs. 5% and 3%; N = 10 im
14 surement of oxygen saturation in the femoral/popliteal arteries and veins during cuff-induced reactiv
15 based therapy in the superficial femoral and popliteal arteries in patients with peripheral artery di
16 or arterial remodelling, in the brachial and popliteal arteries of 13 healthy male subjects (21.6 +/-
17  flow (mean vessel sharpness: 44% vs 30% for popliteal arteries, 45% vs 28% for saphenous arteries; P
18                                              Popliteal arteries, subsequent gastrocnemius feed arteri
19 rtery disease of the superficial femoral and popliteal arteries.
20 ent placement for obstructive lesions of the popliteal artery achieves superior acute technical succe
21 U in the midabdominal aorta to 357 HU in the popliteal artery and 253 HU in the dorsalis pedis or pos
22 with additional 5 seconds +/- 2 to reach the popliteal artery and 7 seconds +/- 4 to reach the ankle
23    The relationship between PI values of the popliteal artery and the number of thrombosed calf veins
24 tion, the superficial femoral artery and the popliteal artery are subject to various forces e.g. thos
25 tentially associated with the development of popliteal artery atherosclerosis in a population-based s
26 tment of symptomatic superficial femoral and popliteal artery disease.
27  stress reaction, periostitis, claudication, popliteal artery entrapment, and peripheral nerve entrap
28 andomization, included the ICD and ACD, ABI, popliteal artery flow with duplex and QOL* at baseline*,
29 udication distances, pressure indices [ABI], popliteal artery flow, and QOL with the short-form 36 He
30                                 Brachial and popliteal artery FMD and DC did not change in control su
31                                   Similarly, popliteal artery FMD increased from baseline (6.2 +/- 0.
32                                Patients with popliteal artery injuries over the 10-year period ending
33 e limb salvage in association with repair of popliteal artery injuries.
34  accepted factors impacting amputation after popliteal artery injury include blunt trauma, prolonged
35 ed to evaluate those factors associated with popliteal artery injury that influence amputation, with
36 ated spectral doppler characteristics of the popliteal artery on the same side as the isolated calf v
37             To investigate the usefulness of popliteal artery spectral doppler findings as a complime
38                        The WSS in the narrow popliteal artery was more sensitive to a reduction in ra
39 n 5 cm in the superficial femoral artery and popliteal artery, and six patients had stenoses or occlu
40 y words were: "superficial femoral artery," "popliteal artery," "angioplasty," "drug-eluting balloon,
41 atients had stenoses or occlusions below the popliteal artery.
42 t to the pulsatility index (PI) value of the popliteal artery.
43 n, plasmid DNA was transferred to the distal popliteal artery.
44 class 2 to 5 who had a de novo lesion in the popliteal artery.
45 lar treatment for obstructive lesions of the popliteal artery.
46 luding superficial femoral, deep femoral and popliteal) artery models that were reconstructed from ma
47             Patients with symptomatic femoro-popliteal atherosclerotic disease undergoing percutaneou
48                                       Though popliteal blood flow appeared to be modulated by respira
49 ign also suggested a correlation between the popliteal-brachial gradient and aortic regurgitation sev
50 olume increased, in-hospital mortality after popliteal bypass decreased from 6.5% to 4.9% (P = 0.0045
51 thmia, aortic valve replacement, and femoral popliteal bypass graft) in isradipine (n=40; 9.05%) vs h
52 ased again by week 8 (6.5 +/- 0.6%), whereas popliteal DC progressively increased from baseline (8.9
53                                              Popliteal DCs transduced with an empty recombinant Adv u
54 rability for aortoiliac disease than femoral popliteal disease.
55 ude femorodistal bypass to ankle or foot and popliteal distal bypass using autogenous vein usually in
56  Iliofemoral DVT (n = 221 [71%]) and femoral-popliteal DVT (n = 79 [25%]) were treated with urokinase
57 y one patient required surgery for a delayed popliteal embolus.
58 h proximal deep-vein thrombosis of the legs (popliteal, femoral, or iliac vein thrombosis).
59 sions of the superficial femoral or proximal popliteal (femoropopliteal) artery.
60 5% CI, -0.2 to 2.1; P=0.116), peak hyperemic popliteal flow (0.0+/-0.4 mL/s; 95% CI, -0.8 to 0.8; P=0
61                        Inter- and intragroup popliteal flow differences at 5/12 were small (P > 0.1).
62 time (PWT), collateral count, peak hyperemic popliteal flow, and capillary perfusion measured by magn
63        Skin grafts were placed distal to the popliteal fossa and mice were euthanized at day 10.
64 xcised collecting lymphatic vessels from the popliteal fossa of mice and removed their muscle cells t
65 nerve block was produced at the level of the popliteal fossa, and behavior was assessed using evoked
66 hy was performed from the iliac crest to the popliteal fossa.
67 ned contiguous images from the pelvis to the popliteal fossa.
68 om mouse collecting lymphatic vessels of the popliteal fossa.
69 eral erythematous halo was noted in the left popliteal fossa; the ulcer had begun as an asymptomatic
70    CT venograms from the iliac crests to the popliteal fossae were reviewed for presence and location
71 in sites relevant to AD: the antecubital and popliteal fossae, nasal tip, and cheek.
72  adjustment for covariates, both carotid and popliteal intimal-medial thicknesses were strongly assoc
73 of Obstructive Superficial Femoral Artery or Popliteal Lesions With A Novel Paclitaxel-Coated Percuta
74  and biomechanical properties of the oblique popliteal ligament (OPL).
75 ells were observed in maximal numbers in the popliteal LN at day 1 and in marginal zones and T-depend
76 and knee joint synovial volumes and draining popliteal LN volumes before and after 8 weeks of treatme
77 erations in contrast agent drainage into the popliteal LN, while lower molecular weight or albumin-bi
78 pliteal LNs, lymphatic drainage from paws to popliteal LNs, and the number of VEGF-C-expressing CD11b
79 he number of lymphatic vessels in joints and popliteal LNs, lymphatic drainage from paws to popliteal
80 reatment significantly decreased the size of popliteal LNs, the number of lymphatic vessels in joints
81 und the cortex and medulla of tumor-draining popliteal LNs, while they were restricted to the cortex
82 ine and chemokine production in the draining popliteal LNs.
83 y in lymphatic vessels afferent to collapsed popliteal LNs.
84 ion on lymph transport from paws to draining popliteal LNs.
85 l formation and the morphology of joints and popliteal LNs.
86 of VEGF-C-expressing CD11b+ myeloid cells in popliteal LNs.
87 model of inflammatory-erosive arthritis, the popliteal lymph node (PLN) enlarges during the pre-arthr
88 ural and functional changes of the adjoining popliteal lymph node (PLN), detectable by contrast-enhan
89 high CD25+) CD8+ T cells within the draining popliteal lymph node (PLN).
90 d by highly expanded B cells in the draining popliteal lymph node (PLN).
91 otyping, and gene expression profiles in the popliteal lymph node and inflamed joints, two pathogenic
92  the inflammatory infiltrate in the draining popliteal lymph node and the site of the infection using
93                                          The popliteal lymph node assay was used to study the role of
94  We analyzed clonally related VDJ genes from popliteal lymph node B cells responding to primary, seco
95     Ab blockade of ICOS ligand, expressed by popliteal lymph node B cells, but not dendritic cells, a
96                  Flow cytometric analysis of popliteal lymph node cells demonstrated similar profiles
97                                   Spleen and popliteal lymph node cells from OVA-primed mice 3 or 7 d
98 vitro proliferative response of OVA-specific popliteal lymph node cells was assessed.
99 d vessel growth; however, the tumor-draining popliteal lymph node featured greatly increased lymphati
100 , amides show inhibitory activity in the rat popliteal lymph node hyperplasia assay.
101 CCR2(+) monocytic dendritic cells within the popliteal lymph node in comparison with B6.WT mice.
102 dary challenge (the increase in the draining popliteal lymph node mass, cell number, and lymphocyte t
103 C cell lines (P < 0.01) in vitro, as well as popliteal lymph node metastases of ESCC cells in nude mi
104 ype littermates to quantify the synovial and popliteal lymph node volumes and the patella and talus b
105 t respond to the host antigens measured by a popliteal lymph node weight gain assay.
106  of myeloid and lymphoid DCs in the draining popliteal lymph node, but not in other lymphoid organs.
107 l as from Ag-induced germinal centers of the popliteal lymph node.
108 -positive cells were readily detected in the popliteal lymph nodes (pLN) of VLP-inoculated mice.
109 arance at the site of infection and draining popliteal lymph nodes (PLNs), and impaired functions of
110 ed B cell accumulation within tumor-draining popliteal lymph nodes (TDLN).
111                            Tissues (draining popliteal lymph nodes [LN], spleens, and thymi) were rem
112                   Furthermore, cLTalpha(-/-) popliteal lymph nodes contained a higher proportion of n
113 estimulation, and secondary responses in the popliteal lymph nodes following in vivo challenge and in
114 erived myeloid dendritic cells trafficked to popliteal lymph nodes from paw pads, the expression of C
115 ces potent IL-4 expression by T cells in the popliteal lymph nodes of mice following footpad immuniza
116                           B lymphocytes from popliteal lymph nodes or Peyer's patch activated in vitr
117 ompared with the paraaortic lymph nodes, the popliteal lymph nodes retain greater than 95% of the rad
118 nt and subsequent MRI of rabbit axillary and popliteal lymph nodes revealed significant contrast enha
119 e for a T cell residing 24 hours in a murine popliteal lymph nodes to interact with a DC was 8%, 58%,
120                            In selected mice, popliteal lymph nodes underwent Cerenkov luminescence im
121                      Fluorescence within all popliteal lymph nodes was easily detected by the FireFly
122 sis of Ly6C(+) macrophages in the ankles and popliteal lymph nodes, decreased migration of monocytes
123                One and 36 h after injection, popliteal lymph nodes, representing the SLNs, were disse
124 antly to early induced IL-4 responses in the popliteal lymph nodes.
125 local (mesenteric) and distant (inguinal and popliteal) lymph nodes of mice with induced polymicrobia
126  after a single fraction of 20 Gy radiation, popliteal lymphadenectomy, and lymphatic vessel ablation
127 e inguinal and popliteal nodes with draining popliteal lymphatic vessel significantly decreased the p
128              IFN-gamma secretion by cultured popliteal lymphocytes decreased in TG animals by 83% aft
129 minal centers in the spleen, plasma cells in popliteal lymphoid nodes, bone marrow cells and granuloc
130 gament in 48%, and the fibular origin of the popliteal muscle in 53% of the patients, whereas standar
131                          Upon stimulation of popliteal node cells, in vitro induction of regulatory c
132           Necropsy at 24 h revealed that the popliteal node on the experimental leg receiving the avi
133 nd enhanced NK cell activity in the draining popliteal node.
134        At both doses (1.7 and 8.4 nmol), the popliteal nodes had higher (P < 0.050) optical fluoresce
135                 Excision of the inguinal and popliteal nodes with draining popliteal lymphatic vessel
136 des) and partial systemic (inguinal, but not popliteal nodes) loss of DCs from lymph nodes in septic
137 ial occlusions and 24 (83%) of 29 SFA and/or popliteal occlusions were longer than 10 cm.
138 tients with tibial occlusions and SFA and/or popliteal occlusions, respectively, as scored with modif
139 ce of symptomatic or asymptomatic DVT in the popliteal or femoral veins.
140 mies, iliac or femoral arteries in 25 (18%), popliteal or tibial arteries in 25 (18%), carotid arteri
141 d with LTbetaR-Ig had no axillary, inguinal, popliteal, or peripancreatic lymph nodes.
142 as absent during mild calf contraction where popliteal outflow was phasic with the concentric phase o
143 onspecific agents were observed for both the popliteal (p < 0.006) and axillary (p < 0.012) nodes.
144 ciated with thickened carotid (p < 0.01) and popliteal (p < 0.05) intimal-medial thicknesses, hormone
145 nd with plasma triglycerides (women only for popliteal) (p < 0.01).
146                                              Popliteal percent injected dose at 24 hr was 3.00 +/- 0.
147 t 6 months, and reinterventions after femoro-popliteal percutaneous transluminal angioplasty up to 1
148 oated balloons in patients undergoing femoro-popliteal percutaneous transluminal angioplasty.
149 pain attributable to superficial femoral and popliteal peripheral artery disease were randomly assign
150 th CEAP clinical class (P < .01) in femoral, popliteal, posterior tibial, peroneal, gastrocnemial, an
151             Van der Woude syndrome (VWS) and popliteal pterygium syndrome (PPS) are autosomal dominan
152                                              Popliteal pterygium syndrome (PPS; OMIM 119500) is a dis
153 sufficiency of IRF6 causes Van der Woude and popliteal pterygium syndrome, 2 syndromic forms of cleft
154 ries of devastating birth defects, including popliteal pterygium syndrome, cocoon syndrome, and Barts
155 genital disorders Van der Woude syndrome and popliteal pterygium syndrome, have a hyperproliferative
156 ermal disorders Bartsocas-Papas syndrome and popliteal pterygium syndrome, respectively.
157 6 (IRF6) underlie Van der Woude syndrome and popliteal pterygium syndrome.
158 otypes in individuals with Van der Woude and popliteal pterygium syndromes, suggesting that the TGFbe
159 fore and after light pulses presented to the popliteal region (behind the knee).
160 R imaging sequence performed parallel to the popliteal tendon proximally was added to our routine stu
161 ral collateral ligament of the knee, and the popliteal tendon.
162 femoral vein (CFV), mid-SFV, distal SFV, and popliteal vein (PV).
163 ases (99%), either the common femoral or the popliteal vein was involved.
164 T) isolated to the calf veins (distal to the popliteal vein) is frequently detected with duplex ultra
165 ed US examinations of the common femoral and popliteal veins only, followed by traditional US of the
166                       The common femoral and popliteal veins were assessed for compressibility.
167 ws thrombosis of the superficial femoral and popliteal veins.Onchest computed tomography (CT) angiogr
168 thrombus in the left superficial femoral and popliteal veins; follow-up chest CT angiogram shows no e
169 ive blood oxygenation time-course of femoral/popliteal vessels in: 1) young healthy subjects (YH) (n
170 ial and superior femoral artery [SFA] and/or popliteal vessels, n = 22).
171 otein cholesterol and carotid (p < 0.01) and popliteal (women only) (p < 0.05) intimal-medial thickne

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top